Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 57, Issue 2

Issues

A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene

Raffaella Accetta
  • SSD Laboratorio Analisi – SMEL Specializzato in Citogenetica e Genetica Medica, ASST Settelaghi, Ospedale di Circolo – Fondazione Macchi, Varese, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Leonardo Campiotti
  • UO Medicina 1, ASST Settelaghi, Ospedale di Circolo – Fondazione Macchi, Varese, Italy
  • Dipartimento di Medicina e Chirurgia, Università degli Studi dell’Insubria, Varese, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lorenzo Elli
  • SSD Laboratorio Analisi – SMEL Specializzato in Citogenetica e Genetica Medica, ASST Settelaghi, Ospedale di Circolo – Fondazione Macchi, Varese, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rosario Casalone
  • SSD Laboratorio Analisi – SMEL Specializzato in Citogenetica e Genetica Medica, ASST Settelaghi, Ospedale di Circolo – Fondazione Macchi, Varese, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Francesco Pallotti
  • Corresponding author
  • SSD Laboratorio Analisi – SMEL Specializzato in Citogenetica e Genetica Medica, ASST Settelaghi, Ospedale di Circolo – Fondazione Macchi, Varese, Italy
  • Dipartimento di Medicina e Chirurgia, Università degli Studi dell’Insubria, Varese, Italy
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-07-27 | DOI: https://doi.org/10.1515/cclm-2018-0349

References

  • 1.

    Chotirat S, Thongnoppakhun W, Wanachiwanawin W, Auewarakul CU. Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders. Blood Cells Mol Dis 2015;54:286–91.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 2.

    Yonal-Hindilerden I, Daglar-Aday A, Hindilerden F, Adakam-Teker B, Yilmaz C, Nalcaci M, et al. The clinical significance of IDH mutations in essential thrombocythemia and primary myelofibrosis. J Clin Med Res 2016;8:29–39.CrossrefPubMedGoogle Scholar

  • 3.

    Tefferi A, Lasho TL, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D, et al. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 2010;24:1302–9.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 4.

    Willander K, Falk IJ, Chaireti R, Paul E, Hermansson M, Grèen H, et al. Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C>T have a prognostic value in acute myeloid leukaemia. Biomarker Res 2014;2:18.CrossrefGoogle Scholar

  • 5.

    Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Biochim Biophys Acta 2014;1846:326–41.PubMedWeb of ScienceGoogle Scholar

  • 6.

    Wagner K, Damm F, Göhring G, Görlich K, Heuser M, Schäfer I, et al. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J Clin Oncol 2010;28:2356–64.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 7.

    Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Krönke J, Bullinger L, et al. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 Mutation without FLT3 internal tandem duplication. J Clin Oncol 2010;28:3636–43.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 8.

    Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrózek K, Margeson D, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 2010;28:2348–55.CrossrefWeb of ScienceGoogle Scholar

  • 9.

    Pardanani A, Lasho TL, Finke CM, Mai M, McClure RF, Tefferi A. IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 2010;24:1146–51.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 10.

    Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 2009;27:4150–4.Web of ScienceCrossrefPubMedGoogle Scholar

  • 11.

    Koszarska M, Bors A, Feczko A, Meggyesi N, Batai A, Csomor J, et al. Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia. Leuk Lymphoma 2013;54:1028–35.Web of ScienceCrossrefPubMedGoogle Scholar

  • 12.

    Thomas X. The management and treatment of acute leukemias in the elderly population. Expert Rev Hematol 2017;10:975–85.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 13.

    Hesterberg R, Müller F, Schmidt WU, Möslein G, Lammers B. Sigmoid diverticulitis in immunosuppressive drug therapy. Chirurg 1994;65:873–6.PubMedGoogle Scholar

  • 14.

    Dalla Valle R, Capocasale E, Mazzoni MP, Busi N, Benozzi L, Sivelli R, et al. Acute diverticulitis with colon perforation in renal transplantation. Transplant Proc 2005;37:2507–10.PubMedCrossrefGoogle Scholar

About the article

Corresponding author: Francesco Pallotti, MD, PhD, Dipartimento di Medicina e Chirurgia, Università degli Studi dell’Insubria, Via Guicciardini 9, 21100 Varese, Italy; and SSD Laboratorio Analisi – SMEL Specializzato in Citogenetica e Genetica Medica, ASST Settelaghi, Ospedale di Circolo – Fondazione Macchi, Varese, Italy, Phone: +39-0332-397141


Received: 2018-04-05

Accepted: 2018-06-20

Published Online: 2018-07-27

Published in Print: 2018-12-19


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 2, Pages e30–e33, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-0349.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Comments (0)

Please log in or register to comment.
Log in